31 Mar

Charting China’s changing pharma patent landscape

China’s attempts to strengthen IP protection and harness innovation have accelerated in recent years. With the country emerging as a critical market for the pharmaceuticals industry, it is crucial to take stock of how these reforms affect the unique challenges faced by life sciences innovators

Adam Houldsworth

Life sciences reporter


[email protected]